Gene · 5764
Papers2,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Different iPSC-derived neural stem cells shows various spectrums of spontaneous differentiation during long term cultivation. | Front Mol Neurosci | 2023 | 37201156 | PubTator, text mining | PubMed |
| An aggregation of human embryonic and trophoblast stem cells reveals the role of trophectoderm on epiblast differentiation. | Cell Prolif | 2023 | 37199067 | PubTator, text mining | PubMed |
| Circ_0087378 intensifies the malignant behavior of non-small cell lung cancer cells in vitro by facilitating DDR1 via sponging miR-199a-5p. | Transl Lung Cancer Res | 2023 | 37197635 | PubTator, text mining | PubMed |
| scRNA-seq and proteomics reveal the distinction of M2-like macrophages between primary and recurrent malignant glioma and its critical role in the recurrence. | CNS Neurosci Ther | 2023 | 37194413 | PubTator, text mining | PubMed |
| The single-cell and spatial transcriptional landscape of human gastrulation and early brain development. | Cell Stem Cell | 2023 | 37192616 | PubTator, text mining | PubMed |
| Feature tracking cardiac magnetic resonance imaging to assess cardiac manifestations of systemic diseases. | Heart Fail Rev | 2023 | 37191926 | PubTator, text mining | PubMed |
| Single-Cell Transcriptome Atlas of Newcastle Disease Virus in Chickens Both In Vitro and In Vivo. | Microbiol Spectr | 2023 | 37191506 | PubTator, text mining | PubMed |
| Galectin-1 promotes angiogenesis and chondrogenesis during antler regeneration. | Cell Mol Biol Lett | 2023 | 37189051 | PubTator, text mining | PubMed |
| Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment. | Adv Nutr | 2023 | 37187454 | PubTator, text mining | PubMed |
| Senescent CD8+ T cells acquire NK cell-like innate functions to promote antitumor immunity. | Cancer Sci | 2023 | 37186472 | PubTator, text mining | PubMed |
| Epigenetic effects of herbal medicine. | Clin Epigenetics | 2023 | 37179342 | PubTator, text mining | PubMed |
| Peptide Regulation of Chondrogenic Stem Cell Differentiation. | Int J Mol Sci | 2023 | 37176122 | PubTator, text mining | PubMed |
| Protein Tyrosine Phosphatase Receptor Zeta 1 as a Potential Target in Cancer Therapy and Diagnosis. | Int J Mol Sci | 2023 | 37175798 | PubTator, text mining | PubMed |
| The online delivery of exercise oncology classes supported with health coaching: a parallel pilot randomized controlled trial. | Pilot Feasibility Stud | 2023 | 37173764 | PubTator, text mining | PubMed |
| Targeting the neural stem cells in subventricular zone for the treatment of glioblastoma: an update from preclinical evidence to clinical interventions. | Stem Cell Res Ther | 2023 | 37170286 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| Exosomal circ-AHCY promotes glioblastoma cell growth via Wnt/β-catenin signaling pathway. | Ann Clin Transl Neurol | 2023 | 37150844 | PubTator, text mining | PubMed |
| Inferring ligand-receptor cellular networks from bulk and spatial transcriptomic datasets with BulkSignalR. | Nucleic Acids Res | 2023 | 37144485 | PubTator, text mining | PubMed |
| Blood Proteomics Analysis Reveals Potential Biomarkers and Convergent Dysregulated Pathways in Autism Spectrum Disorder: A Pilot Study. | Int J Mol Sci | 2023 | 37108604 | PubTator, text mining | PubMed |
| A Systematic Review of the Heterogenous Gene Expression Patterns Associated with Multidrug Chemoresistance in Conventional Osteosarcoma. | Genes (Basel) | 2023 | 37107591 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5764/papers?page=20